Innovation
38 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 10,713 times.
| Year | Filings |
|---|---|
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 5 |
Social engagement
Social engagement: 12K social following, 7 posts in the last 12 months — around the industry typical range.
Investor mix
16 investors on record; lead investors include Auriga Partners, Shavit Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 31% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 9 | 56% |
Recent activity
13 Jun 2026
Event
Aplastic Anemia & MDS International Foundation Patient Conference
5 May 2026
Partnership
American Biotech Innovation Alliance (ABIA)
29 Aug 2025
Product launch
Omidubicel for the Treatment of Severe Aplastic Anemia (SAA)